DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 12126 - 12150 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▼ Gene Name UniProt ID
C0002170 Alopecia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0346647 Malignant neoplasm of pancreas ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0014070 Encephalomyelitis ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0025517 Metabolic Diseases ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0023467 Leukemia, Myelocytic, Acute ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0009402 Colorectal Carcinoma ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0010606 Adenoid Cystic Carcinoma ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0400966 Non-alcoholic Fatty Liver Disease ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0000889 Acanthosis Nigricans ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0085636 Photophobia ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0013238 Dry Eye Syndromes ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0162309 Adrenoleukodystrophy ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C1527231 Adrenomyeloneuropathy ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0011603 Dermatitis ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0027651 Neoplasms ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0020456 Hyperglycemia ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0005697 Neurogenic Urinary Bladder ELOVL1 64834 ELOVL fatty acid elongase 1 Q9BW60
C0279702 Conventional (Clear Cell) Renal Cell Carcinoma ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C0086651 Mucopolysaccharidosis, MPS-IV-A ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C3160718 PARKINSON DISEASE, LATE-ONSET ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C0007134 Renal Cell Carcinoma ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C1335177 Ovarian Serous Adenocarcinoma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0006142 Malignant neoplasm of breast ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0376358 Malignant neoplasm of prostate ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0006826 Malignant Neoplasms ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024